Impavido
Active Ingredient(s): MiltefosineFDA Approved: * March 19, 2014
Pharm Company: * PALADIN THERAPEUTICS INC
Category: Antiprotozoal / Anthelmintic
Miltefosine, sold under the trade name Impavido among others, is a medication mainly used to treat leishmaniasis and free-living amoeba infections such as Naegleria fowleri and Balamuthia mandrillaris.[2] This includes the three forms of leishmaniasis: cutaneous, visceral and mucosal.[3] It may be used with liposomal amphotericin B or paromomycin.[4] It is taken by mouth.[3] Common side effects include vomiting, abdominal pain, f... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.